Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Minnesota › Rochester
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Rochester, MN keessatti
Qorannoo 37 Kansara Qara'a Non-Small Cell f Rochester fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #68, Rochester
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic in Rochester, Rochester
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Rochester
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Mayo Clinic-Rochester /ID# 274512, Rochester
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Namoota walitti qabaa jiraSadarkaa 3
- Mayo Clinic - Rochester ( Site 0073), Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mayo Clinic Rochester, Rochester
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic Rochester, Rochester
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic, Rochester
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Namoota walitti qabaa jiraSadarkaa 3
- Mayo Clinic - Rochester ( Site 0148), Rochester
Pan-tumor MRD Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mayo Clinic, Rochester
An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic, Rochester
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Rochester
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Mayo Clinic, Rochester
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mayo Clinic (Rochester), Rochester
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic, Rochester
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Rochester, Rochester
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Rochester
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Clinic, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Clinic, Rochester
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Clinic - Rochester, Rochester
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Mayo Clinic-Rochester, Rochester
A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Mayo Clinic in Rochester, Rochester
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Namoota walitti qabaa jiraSadarkaa 3
- Mayo Clinic in Rochester, Rochester
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Namoota walitti qabaa jiraSadarkaa 1/2
- Mayo Clinic Hospital - Rochester, MN, Rochester
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Clinic Rochester, Rochester
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Clinic Cancer Center, Rochester
- Mayo Clinic, Rochester
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- Mayo Clinic Rochester, Rochester
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Mayo Clinic Comprehensive Cancer Center, Rochester
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Namoota walitti qabaa jiraSadarkaa 3
- Mayo Clinic, Rochester
Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic in Rochester, Rochester
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Namoota walitti qabaa jiraSadarkaa 1/2
- Mayo Clinic Cancer Center, Rochester
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mayo Clinic, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mayo Clinic in Rochester, Rochester
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Mayo Clinic (Data Collection Only), Rochester
Insomnia in Patients With Metastatic Lung Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- Mayo Clinic, Rochester
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 120
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 56
- Washington, DCQorannoo 55
Qorannoo biroo Rochester keessatti
- Saree OljooQorannoo 42
- Kansara MetastatikiiQorannoo 31
- Saree (Gosoota Hunda)Qorannoo 30
- Kansarii ColorectalQorannoo 29
- Kansarii OvariiQorannoo 29
- Myeloma Baay’eeQorannoo 24
- Kansarii ProstateQorannoo 22
- Cufama OnneeQorannoo 22
- Kansarii PancreasQorannoo 22
- Dhibee QaraQorannoo 20
- Kansa EndometiriyaaliiQorannoo 20
- Luukemiya Limfoositiikii KeessummaaQorannoo 19
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.